1. Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome 
Esther J. Kim, Daniel J. Lewis, Madeleine Duvic 
Journal of Investigative Dermatology 
Volume 137, Issue 9, Pages (September 2017)
DOI: /j.jid
Copyright © 2017 The Authors Terms and Conditions

2. Figure 1
Pathogenetic and clinical features of PCLBCL-LT in different stages. PCLBCL-LT, primary cutaneous large B-cell lymphoma, leg-type.
Journal of Investigative Dermatology  , DOI: ( /j.jid )
Copyright © 2017 The Authors Terms and Conditions

3. Figure 2
Overview of NF-κB activation and the genetic aberrancies in PCLBCL-LT versus Sézary syndrome. Affected molecules in PCLBCL-LT are indicated in red, affected molecules in Sézary syndrome are indicated in blue, and therapeutic targets are indicated in green. CARD11, caspase recruitment domain family member 11; CD79A, cluster of differentiation 79A; CD79B, cluster of differentiation 79B; MYD88, myeloid differentiation primary response gene; PCLBCL-LT, primary cutaneous large B-cell lymphoma, leg-type; TLR, toll-like receptor.
Reprinted from Koens et al., 2014, with permission from Elsevier.
Journal of Investigative Dermatology  , DOI: ( /j.jid )
Copyright © 2017 The Authors Terms and Conditions